Hematologics

Hematologics Inc, based in Seattle, WA, is a renowned leader in Measurable Residual Disease testing for Acute Leukemia, offering innovative diagnostic and monitoring solutions for myeloid and lymphoid neoplasms. Their comprehensive services include advanced flow cytometry, molecular analysis, cytogenetics, and plasma cell enrichment for precise diagnosis and treatment monitoring.

With a team of experts specializing in various diagnostic fields, Hematologics ensures all testing is conducted in-house, allowing for efficient analysis and rapid response to unexpected findings. Their cutting-edge approach to integrating genotype and phenotype data revolutionizes the field of hematology, providing valuable insights into clonal evolution and cytogenetic disruptions in myeloid cell maturation.

Generated from the website